These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10636386)

  • 21. Methionine-loading and random homocysteine tests have no added value in risk assessment for venous and arterial thrombosis.
    Lijfering WM; Veeger NJ; Brouwer JL; van de Poel MH; van der Meer J
    J Thromb Haemost; 2007 Mar; 5(3):614-6. PubMed ID: 17181828
    [No Abstract]   [Full Text] [Related]  

  • 22. Is hyperhomocysteinemia a risk factor or a consequence of coronary heart disease?
    Cattaneo M
    Arch Intern Med; 2001 Nov; 161(21):2628-9. PubMed ID: 11718612
    [No Abstract]   [Full Text] [Related]  

  • 23. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The mechanisms of hyperhomocysteinemia in coronary heart disease].
    Gao W; Jiang N; Zhu G
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):821-3. PubMed ID: 11038775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine: the Rubik's cube of cardiovascular risk factors.
    Milani RV; Lavie CJ
    Mayo Clin Proc; 2008 Nov; 83(11):1200-2. PubMed ID: 18990317
    [No Abstract]   [Full Text] [Related]  

  • 26. [Homocysteine--risk factor or risk indicator?].
    Rafflenbeul W
    MMW Fortschr Med; 2005 Nov; 147(44):28-30. PubMed ID: 16302487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of plasma homocyst(e)ine in arterial occlusive diseases.
    Malinow MR; Stampfer MJ
    Clin Chem; 1994 Jun; 40(6):857-8. PubMed ID: 8087977
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease.
    Haim M; Tanne D; Goldbourt U; Doolman R; Boyko V; Brunner D; Sela BA; Behar S
    Cardiology; 2007; 107(1):52-6. PubMed ID: 16763372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing restenosis in CAD patients. Folate therapy reduces homocysteine--and risk.
    All AK; Bobadilla RV
    Adv Nurse Pract; 2004 Mar; 12(3):79-82. PubMed ID: 15038191
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperhomocysteinemia and occlusive vascular disease: an emergent role for fibroblast growth factor 2.
    Medina MA
    Circ Res; 2008 Apr; 102(8):869-70. PubMed ID: 18436800
    [No Abstract]   [Full Text] [Related]  

  • 31. [Homocysteine as a coronary risk factor].
    Derbeneva SA; Pogozheva AV
    Vopr Pitan; 2003; 72(5):43-8. PubMed ID: 14619617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel risk factors and markers for coronary disease.
    Ridker PM
    Adv Intern Med; 2000; 45():391-418. PubMed ID: 10635056
    [No Abstract]   [Full Text] [Related]  

  • 34. Betaine in wine: answer to the French paradox?
    Mar MH; Zeisel SH
    Med Hypotheses; 1999 Nov; 53(5):383-5. PubMed ID: 10616037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Homocysteine and coronary events in coronary disease patients].
    Ambrosi P; Barlatier A; Artaud-Navarro A; Habib G; Ferracci A; Boussuges A; Garçon D; Bouvenot G; Luccioni R
    Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):185-9. PubMed ID: 12555379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
    Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary artery vasculitis and myocardial infarction with systemic lupus erythematosus.
    Benisch BM; Pervez N
    N Y State J Med; 1974 May; 74(5):873-4. PubMed ID: 4545415
    [No Abstract]   [Full Text] [Related]  

  • 38. Coronary artery obstruction and myocardial infarction resulting from nonpenetrating chest trauma.
    Jenkins JL; Nishimura A
    Tex Med; 1975 Dec; 71(12):78-83. PubMed ID: 1198346
    [No Abstract]   [Full Text] [Related]  

  • 39. Homocysteine and the heart.
    Turner SL; Bechtel GA
    Adv Nurse Pract; 1999 Mar; 7(3):71-3. PubMed ID: 10373803
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasma homocysteine levels in cardiovascular disease, malaria and protein-energy malnutrition in Sudan.
    Abdel GA; Abdullah SH; Kordofani AY
    East Mediterr Health J; 2009; 15(6):1432-9. PubMed ID: 20218135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.